medRxiv PreprintsInternational19 November 2026
Upper respiratory microbiome and host immune signatures associated with SARS-CoV-2 susceptibility and illness in a human challenge model
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
The upper respiratory tract (URT) microbiome modulates the local mucosal immune environment, with potential implications for respiratory viral infection susceptibility and outcomes. We leveraged a first-in-human SARS-CoV-2 challenge study in 34 healthy young adults, 18 of whom became infected, to characterize host gene expression and microbiome composition and dynamics in nasal and throat samples collected before viral inoculation and over the subsequent 14 days. Compared with participants who remained uninfected, participants who became infected had elevated baseline nasal expression of gene
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.